Futibatinib

CHEMBL3701238 Phase 4 Aprobado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
418.4 g/mol
LogP
2.0
Phase
4

This oral medication selectively and irreversibly inhibits FGFR1-4, receptors that drive the growth of certain cancers when mutated or overactive. It is used to treat cholangiocarcinoma with FGFR2 gene rearrangements and is being studied in bladder and breast cancers with FGFR alterations.

Peso molecular

418,4000 g/mol

LogP

2,00

TPSA

108,00 Ų

Regla de cinco de Lipinski

Cumple

Áreas terapéuticas

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estructura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C=CC(=O)N1CC[C@H](n2nc(C#Cc3cc(OC)cc(OC)c3)c3c(N)ncnc32)C1

InChI

InChI=1S/C22H22N6O3/c1-4-19(29)27-8-7-15(12-27)28-22-20(21(23)24-13-25-22)18(26-28)6-5-14-9-16(30-2)11-17(10-14)31-3/h4,9-11,13,15H,1,7-8,12H2,2-3H3,(H2,23,24,25)/t15-/m0/s1

Molecular Formula

C22H22N6O3

HBD / HBA

1 / 7

Enlaces Rotables

6

Átomos Pesados

31

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

This oral medication selectively and irreversibly inhibits FGFR1-4, receptors that drive the growth of certain cancers when mutated or overactive. It is used to treat cholangiocarcinoma with FGFR2 gene rearrangements and is being studied in bladder and breast cancers with FGFR alterations.

Yes, Futibatinib is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3701238. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 71621331. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.